We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+23.97%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$69.6B
AUM Growth
+$8.07B
Cap. Flow
+$567M
Cap. Flow %
0.82%
Top 10 Hldgs %
16.2%
Holding
2,221
New
173
Increased
863
Reduced
913
Closed
183

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$436M
2
RF icon
Regions Financial
RF
+$313M
3
ADP icon
Automatic Data Processing
ADP
+$289M
4
INTU icon
Intuit
INTU
+$288M
5
NFLX icon
Netflix
NFLX
+$253M

Sector Composition

Rank Sector Weight
1 Technology 28.03%
2 Healthcare 13.59%
3 Industrials 13.09%
4 Financials 10.33%
5 Consumer Discretionary 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WDFC icon
1026
WD-40
WDFC
$2.55B
$1.86M ﹤0.01%
7,628
MUFG icon
1027
Mitsubishi UFJ Financial
MUFG
$267B
$1.85M ﹤0.01%
93,042
-14,741
-14% -$278K
VNO icon
1028
Vornado Realty Trust
VNO
$6.45B
$1.85M ﹤0.01%
47,076
-45,461
-49% -$1.47M
PRG icon
1029
PROG Holdings
PRG
$1.45B
$1.85M ﹤0.01%
39,664
+1,764
+5% +$61.5K
VCYT icon
1030
Veracyte
VCYT
$3.23B
$1.85M ﹤0.01%
31,432
+27,257
+653% +$1.14M
CRCL
1031
Circle Internet Group
CRCL
$21.9B
$1.83M ﹤0.01%
29,295
+5,005
+21% +$487K
WOR icon
1032
Worthington Enterprises
WOR
$2.66B
$1.8M ﹤0.01%
33,434
+8,423
+34% +$469K
UTHR icon
1033
United Therapeutics
UTHR
$21.5B
$1.79M ﹤0.01%
3,309
-144
-4% -$81.1K
NICE icon
1034
Nice
NICE
$6.09B
$1.78M ﹤0.01%
19,550
XYL icon
1035
Xylem
XYL
$25.1B
$1.75M ﹤0.01%
14,805
-8,787
-37% -$1.01M
GT icon
1036
Goodyear
GT
$1.51B
$1.74M ﹤0.01%
264,092
+127,544
+93% +$821K
MATV icon
1037
Mativ Holdings
MATV
$656M
$1.73M ﹤0.01%
228,939
-86,413
-27% -$744K
RYAN icon
1038
Ryan Specialty Holdings
RYAN
$4.79B
$1.72M ﹤0.01%
45,548
+5,156
+13% +$175K
CYRX icon
1039
CryoPort
CYRX
$826M
$1.71M ﹤0.01%
108,622
-100,315
-48% -$1.29M
DSP icon
1040
Viant Technology
DSP
$266M
$1.7M ﹤0.01%
134,263
+10,395
+8% +$117K
THC icon
1041
Tenet Healthcare
THC
$21B
$1.7M ﹤0.01%
9,063
+1,040
+13% +$191K
TLN
1042
Talen Energy Corp
TLN
$13.5B
$1.68M ﹤0.01%
4,384
-155
-3% -$56.8K
ELV icon
1043
Elevance Health
ELV
$90.6B
$1.65M ﹤0.01%
4,277
+3,311
+343% +$1.23M
ASH icon
1044
Ashland
ASH
$3.22B
$1.64M ﹤0.01%
24,846
-1,375
-5% -$79.9K
IBN icon
1045
ICICI Bank
IBN
$102B
$1.63M ﹤0.01%
56,053
-4,592
-8% -$124K
BYD icon
1046
Boyd Gaming
BYD
$5.53B
$1.62M ﹤0.01%
18,330
-945
-5% -$80.4K
CAL icon
1047
Caleres
CAL
$425M
$1.61M ﹤0.01%
130,118
-24,156
-16% -$313K
ROKU icon
1048
Roku
ROKU
$23.3B
$1.61M ﹤0.01%
11,645
-424,732
-97% -$51.8M
SBS icon
1049
Sabesp
SBS
$18.4B
$1.6M ﹤0.01%
276,663
-31,662
-10% -$192K
MRCY icon
1050
Mercury Systems
MRCY
$5.23B
$1.57M ﹤0.01%
12,848
+2,507
+24% +$239K

Similar funds

Federated Hermes's Q2 2026 Portfolio in Review

As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
  • Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
  • Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
  • Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
  • Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
  • Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
  • Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.